Literature DB >> 14745211

History repeats itself.

Philip L Gildenberg1.   

Abstract

Although many advances in stereotactic surgery appear to be of recent origin, there are precedents in the literature documenting the planting of those seeds that eventually grew into common procedures. Pallidotomy was the first stereotactic procedure in humans that used the Spiegel-Wycis apparatus in 1947. Other targets for Parkinson's disease have their roots in the decade following that. Using stereotactic techniques to target solid or cystic lesions was introduced in the 1950's, when either calcification or pneumoencephalography were necessary to visualize the mass. One of the first uses of computers in surgery was in stereotaxis. Infusion of a neurotransmitter was first done over 30 years ago. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14745211     DOI: 10.1159/000075162

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  4 in total

1.  Psychosurgery in the History of Stereotactic Functional Neurosurgery.

Authors:  Lara Rzesnitzek; Marwan Hariz; Joachim K Krauss
Journal:  Stereotact Funct Neurosurg       Date:  2020-06-29       Impact factor: 1.875

2.  Deep Brain Stimulation for Intractable Obsessive-Compulsive Disorder and Treatment-Resistant Depression.

Authors:  Benjamin M Borron; Darin D Dougherty
Journal:  Focus (Am Psychiatr Publ)       Date:  2022-01-25

Review 3.  Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety.

Authors:  Lars Wojtecki; Stefan Jun Groiss; Christian Johannes Hartmann; Saskia Elben; Sonja Omlor; Alfons Schnitzler; Jan Vesper
Journal:  Brain Sci       Date:  2016-08-30

4.  A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies.

Authors:  Peter J Grahn; Grant W Mallory; Obaid U Khurram; B Michael Berry; Jan T Hachmann; Allan J Bieber; Kevin E Bennet; Hoon-Ki Min; Su-Youne Chang; Kendall H Lee; J L Lujan
Journal:  Front Neurosci       Date:  2014-06-25       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.